Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Sophie Reffet"'
1
Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers
Autor: Fanny Buron, Lionel Badet, Olivier Thaunat, Emmanuel Morelon, Sophie Reffet
Publikováno v: Current Diabetes Reports. 21
Grafted beta cells are lost because of recurrence of T1D and/or allograft rejection, two conditions diagnosed with pancreas graft biopsy, which is invasive and impossible in case of islet transplantation. This review synthetizes the current pathophys
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6a989a7dfaec9b0919bfe4f3ce9dee0
https://doi.org/10.1007/s11892-021-01386-4
Zobrazit plný text záznamu
2
Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers
Autor: Fanny, Buron, Sophie, Reffet, Lionel, Badet, Emmanuel, Morelon, Olivier, Thaunat
Publikováno v: Current diabetes reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 21(6)
Grafted beta cells are lost because of recurrence of T1D and/or allograft rejection, two conditions diagnosed with pancreas graft biopsy, which is invasive and impossible in case of islet transplantation. This review synthetizes the current pathophys
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::741dc1ed7f3b89b5622cb7d1c2a67e9f
https://pubmed.ncbi.nlm.nih.gov/33895937
Zobrazit plný text záznamu
3
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
Autor: Sophie Reffet, Stéphane Dalle, Lucien Marchand, Charles Thivolet, Nicole Fabien, Emmanuel Disse, Julien Vouillarmet, Christine Cugnet-Anceau
Publikováno v: Acta diabetologica
Acta diabetologica, 2019, 56 (12), pp.1239--1245. ⟨10.1007/s00592-019-01402-w⟩
Immune checkpoint inhibitors (CPI) are increasingly being used in oncology, and many autoimmune side effects have been described. Diabetes mellitus (DM) has been reported in approximately 1% of subjects treated with programmed cell death-1 and progra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cf7580fcdfdce130547728c6f643f8
https://pubmed.ncbi.nlm.nih.gov/31423559
Zobrazit plný text záznamu
5
Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype
Autor: Charles Thivolet, Karim Chikh, Lucien Marchand, Nicole Fabien, Sophie Reffet, Julien Vouillarmet, Christine Cugnet-Anceau, Arnaud Thivolet, Stéphane Dalle
Publikováno v: Acta Diabetol
Acta Diabetol, 2019, 56 (4), pp.441--448. ⟨10.1007/s00592-018-1234-8⟩
AIMS: Programmed cell death-1 and programmed death ligand 1 (PD-1/PD-L1) inhibitors restore antitumor immunity, but many autoimmune side-effects have been described. Diabetes mellitus is a rare complication, and little data concerning its pathophysio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113b7ed78d7f74086f683082d650dfb4
https://hal.archives-ouvertes.fr/hal-02195223
Zobrazit plný text záznamu
6
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d’endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie – dialyse – transplantation (SFNDT)
Autor: Nassim Kamar, Thierry Berney, Georges Karam, Gabriella Pittau, Oriana Ciacio, F. Buron, Julien Branchereau, M. Chetboun, Karine Moreau, Bogdan Catargi, Pierre Cattan, Sophie Reffet, Kristell Le Mapihan, Michelle Elias, Jean-Pierre Duffas, Marie-Noelle Peraldi, Sandrine Lablanche, Paolo Malvezzi, Jean-Emmanuel Serre, Gianluca Donatini, Laurence Kessler, Emmanuel Cuellar, Marie Frimat, Sophie Ohlmann, Chailloux Lucy, Xavier Tillou, Jean-Pierre Riveline, Fabrizio Panaro, Marie-Christine Vantyghem, Antoine Durrbach, Tiphaine Vidal-Trecan, François Pattou, Pierre-Yves Benhamou, Mathieu Armanet, Anne Wojtusciszyn, Hélène Hanaire, Sophie Caillard, Vincent Melki, Antonio Sacunha, Emmanuel Morelon, L. Esposito, Choukroun Gabriel, Anne Lejay, Francois Gaudez, Gilles Blancho, Gaëtan Prévost, Lionel Badet, Valérie Garrigue, Rachel Tetaz, Olivier Thaunat, Axel Andres, Fabrice Muscari
Publikováno v: Journal of Diabetes & Metabolism
Journal of Diabetes & Metabolism, OMICS International, 2018, ⟨10.1016/j.diabet.2018.07.006⟩
BASE-Bielefeld Academic Search Engine
While either pancreas or pancreatic islet transplantation can restore endogenous insulin secretion in patients with diabetes, no beta-cell replacement strategies are recommended in the literature. For this reason, the aim of this national expert pane
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44182a65147bc6b645e4c75ff25e79ca
https://hal.univ-grenoble-alpes.fr/hal-01930587
Zobrazit plný text záznamu
8
Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?
Autor: Guillaume Charpentier, A.M. Leguerrier, Dured Dardari, C. Vigeral, L. Millot, A. Penfornis, Laurence Kessler, Eric Renard, Jean-Louis Quesada, Bruno Guerci, Charles Thivolet, Anne Vambergue, Sophie Reffet, O. Ronsin, H. Mosnier-Pudar, François Moreau, Hélène Hanaire, C. Fagour, Sylvia Franc, Serge Halimi, P. Winiszewski, Sophie Borot, P.Y. Benhamou
Publikováno v: Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2014, 40 (1), pp.61-6. ⟨10.1016/j.diabet.2013.09.001⟩
International audience; AIM: In the TELEDIAB-1 study, the Diabeo system (a smartphone coupled to a website) improved HbA1c by 0.9% vs controls in patients with chronic, poorly controlled type 1 diabetes. The system provided two main functions: automa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9dd6f8f37f42f20ba9894230fae8fa7
https://hal.archives-ouvertes.fr/hal-01859454
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje